ORICULA THERAPEUTICS, LLC
Small molecule compounds that prevent aminoglycoside antibiotic-induced ototoxicity (hearing loss) in patients
- Sector
- Biotech
- Headquarters
- SEATTLE, WA
- Founded
- 2013
- Latest Form D
- $500K offered, Apr 2020
- Total capital
- $2.2M
- Federal grants
- $2.1M
- 2 awards · 2016–2017
- Rank in peer group#12 of 326
- Private capital raised
- $175K
- 5 Form D · last Apr 2020
- 78 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 1 pending · first 2016
- Rank in peer group#58 of 326
Capital timeline
Latest events
- Offering registeredForm D · SEC · 5th filing$500K
- Private capital raisedForm D · SEC · 4th filing$30K
- Private capital raisedForm D · SEC · 3rd filing$25K
- Federal grantHealth and Human S · Phase II · Novel therapeutic agent to prevent hearing loss during aminoglycoside therapy$1.1M
- Federal grantHealth and Human S · Phase II · Novel therapeutic agent to prevent hearing loss during aminoglycoside therapy$946K
- Private capital raisedForm D · SEC · 2nd filing$45K
- Private capital raisedForm D · SEC · 1st filing$75K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#12 · top 4%
- Granted patents#58 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Malcolm GleserResearcherExecutive Officer, Director, PromoterLinked by $2.1M in grants as PI
- Ed RubelDirector, PromoterNamed in SEC Form D filings
- Vince GroppiDirector, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 3- GrantedCompounds And Methods For Preventing Or Treating Sensory Hair Cell DeathUSPTOUS 10,399,994
- GrantedCompounds And Methods For Preventing Or Treating Sensory Hair Cell DeathUSPTOUS 9,493,482
- PendingCompounds And Methods For Preventing Or Treating Sensory Hair Cell DeathUSPTOApplication 62113245
Related companies, and why
- Syllable Life Sciences, Inc.Similar federal contract value in Biotech · null in contracts
- Navigator MedicinesSimilar federal contract value in Biotech · null in contracts
- CIBOTS, INC.Similar federal contract value in Biotech · null in contracts
- Quantum Insights, Inc.Similar federal contract value in Biotech · null in contracts
- TALUS BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- Hummingbird Nano, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .